Advertisement

Topics

"Myelofibrosis Global Manufacturers Marketed Phase Drugs Landscape 2017" Drugs and Medication Database

12:58 EST 20th January 2019 | BioPortfolio

Here are the most relevant "Myelofibrosis Global Manufacturers Marketed Phase Drugs Landscape 2017" Drugs and Medications that we have found in our database.

More Information about "Myelofibrosis Global Manufacturers Marketed Phase Drugs Landscape 2017" on BioPortfolio

We have published hundreds of Myelofibrosis Global Manufacturers Marketed Phase Drugs Landscape 2017 news stories on BioPortfolio along with dozens of Myelofibrosis Global Manufacturers Marketed Phase Drugs Landscape 2017 Clinical Trials and PubMed Articles about Myelofibrosis Global Manufacturers Marketed Phase Drugs Landscape 2017 for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Myelofibrosis Global Manufacturers Marketed Phase Drugs Landscape 2017 Companies in our database. You can also find out about relevant Myelofibrosis Global Manufacturers Marketed Phase Drugs Landscape 2017 Drugs and Medications on this site too.

Showing "Myelofibrosis Global Manufacturers Marketed Phase Drugs Landscape 2017" Drugs and Medications 1–25 of 51

Possibly Relevant

Epinephrine hypospray(r) [Langford Research Institute]

Epinephrine HypoSpray

Jakafi [Incyte Corporation]

These highlights do not include all the information needed to use JAKAFI safely and effectively. See full prescribing information for JAKAFI. JAKAFI (ruxolitinib) tablets, for oral use Initial U.S. Approval: 2011

Oxygen [Sky Oxygen]

Oxygen Labels

Docetaxel [Jiangsu Hengrui Medicine Co., Ltd.]

These highlights do not include all the information needed to use DOCETAXEL INJECTION safely and effectively. See full prescribing information for DOCETAXEL INJECTION. DOCETAXEL injection (concentrate and diluent), for intravenous use Initial U.S. Approva

Oxygen [Praxair Mexico, S. de R.L. de C.V]

NA

Prednisone [Northwind Pharmaceuticals]

NA

Carbamazepine [Aidarex Pharmaceuticals LLC]

These highlights do not include all the information needed to use carisoprodol safely and effectively. See full prescribing information for carisoprodol tablets, USP. Carisoprodol Tablets, USP for Oral use CIVInitial U.S. Approval: 1959

Metronidazole [Prasco Laboratories]

These highlights do not include all the information needed to use Metronidazole Gel, 1% safely and effectively. See full prescribing information for Metronidazole Gel, 1%]. Metronidazole Gel Metronidazole [Gel] for [Topical] use Initial U.S. Approval: [

Fenofibrate [Northwind Pharmaceuticals]

NA

Chlorure de potassium proamp [Laboratoire Aguettant]

Potassium Chloride for Injection Concentrate, USP

Tricare prenatal 2-part daily prenatal vitamin system [Medecor Pharma, LLC]

NA

Metrolotion [Galderma Laboratories, L.P.]

MetroLotion®(metronidazole lotion)Topical Lotion, 0.75% Rx Only FOR TOPICAL USE ONLY(NOT FOR OPHTHALMIC USE)

Niacor [Avondale Pharmaceuticals, LLC]

NIACOR (Niacin Tablets, USP) 500 mg

Niacor [Upsher-Smith Laboratories, LLC]

NIACOR (Niacin Tablets, USP)500 mg

Metrocream [Galderma Laboratories, L.P.]

MetroCream®(metronidazole topical cream)Topical Cream, 0.75%      Rx Only FOR TOPICAL USE ONLY(NOT FOR OPHTHALMIC USE)

Cpda-1 [Fenwal, Inc.]

Metrogel [Galderma Laboratories, L.P.]

These highlights do not include all the information needed to use METROGEL (metronidazole) Gel, 1% safely and effectively. See full prescribing information for METROGEL (metronidazole) Gel, 1% METROGEL® (metronidazole) Gel, 1% For topical use only. Initi

Aktipak [Cutanea Life Sciences, Inc.]

Aktipak (erythromycin and benzoyl peroxide) Gel, 3%/5%For Dermatological Use Only – Not for Ophthalmic Use

Cpda-1 [Fenwal, Inc.]

CPDA-1 BLOOD-PACK™ Unit

Cpda-1 [Fenwal, Inc.]

Triple Blood-Pack™ Unit Anticoagulant Citrate Phosphate Dextrose Adenine Solution (CPDA-1)

Fluoxetine [DirectRX]

FLUOXETINE

Iclusig [Millennium Pharmaceuticals, Inc.]

These highlights do not include all the information needed to use ICLUSIG safely and effectively. See full prescribing information for ICLUSIG. ICLUSIG(ponatinib) tablets, for oral use Initial U.S. Approval: 2012

Tricare prenatal [Medecor Pharma, LLC]

NA

Cpda-1 [Fenwal, Inc.]

Double Blood-PackUnit Anticoagulant Citrate Phosphate Dextrose Adenine Solution (CPDA-1)

Cpda-1 [Fenwal, Inc.]



Advertisement
Quick Search
Advertisement
Advertisement